Hemolytic disease of the newborn due to the Scianna antibody, anti-Sc2.
BACKGROUND
Alloantibodies to the low-frequency antigen Scianna 2 (Sc2) are uncommon and not previously reported to cause immune hemolysis.


METHODS
A group B, Rh-negative infant born to a group B, Rh-positive mother had a 2+ direct antiglobulin test, as well as modest hyperbilirubinemia and a hematocrit of 45 percent. Ongoing immune hemolysis led to a hematocrit of 17.3 percent on Day 20 of life, and the infant required hospitalization and red cell transfusions. The routine maternal antibody screen was negative, but anti-Sc2 was detected during work-up for a low-frequency red cell antigen, and the father's red cells typed as Sc:1,2.


CONCLUSIONS
Anti-Sc2 can cause clinically significant hemolytic disease of the newborn. Although the antibody is uncommon, its frequency and hemolytic potential may be underappreciated, in part because investigations often are not carried out in the infant whose red cells are ABO-incompatible with maternal blood.
DeMarco
M
M
Department of Pathology, Charles A. Dana Research Institute, Boston, Massachusetts.
Uhl
L
L
Fields
L
L
Pacini
D
D
Gorlin
J B
JB
Kruskall
M S
MS
D000328:Adult; D001789:Blood Group Antigens / Q000276:immunology; D004899:Erythroblastosis, Fetal / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000009:adverse effects*
D001789:Blood Group Antigens; D007518:Isoantibodies; C091012:Scianna antibody